New Content  edit
Get The App!

Loading the player...
If Peripheral Blasts Increase While on Ruxolitinib, is That Considered Treatment Failure?
Share URL
Embed Code
Share by Email
Send to social websites
Report this video as inappropriate You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email. Select your reason
Sexual Content Violent or Repulsive Content
Hateful or Abusive Content Harmful Dangerous Acts
Child Abuse Spam
Dr. John Mascarenhas, Mt. Sinai School of Medicine, answers the following questions: If peripheral blasts increase while on ruxolitinib, is that considered treatment failure? Would you increase the dosage or add/switch therapy?